SlidesetHIVINTEREST 2016Progress on viral load monitoring, laboratory quality assurance, point of care | John Nkengasong, PhDView Slideset
SlidesetHIVINTEREST 2016Acquired Drug Resistance: Causes, Patterns, and Implications for SSA | Coumba Toure Kane, PharmD, PhDView Slideset
NPNicholas PatonMD, FRCPSlidesetHIVINTEREST 2016Evolving Treatment Paradigms: Relevance in Resource- Limited Settings | Nicholas Paton, MD, FRCPView Slideset
SlidesetHIVINTEREST 2016HIV Leadership and Financing Strategies for Countries in sub-Saharan Africa | Debrework Zewdie, PhDView Slideset
SlidesetHIVINTEREST 2016Progress in Hepatitis B and C in sub-Saharan Africa | Magloire Biwole Sida, MDView Slideset
SlidesetHIVINTEREST 2016(Abstract) Outcomes of second-line therapy in HIV positive adults attending for routine care at Yaoundé Central Hospital | A.O. Mafotsing FopoussiView Slideset
SlidesetHIVINTEREST 2016(Abstract) HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges | A.F. AghokengView Slideset
SlidesetHIVINTEREST 2016(Abstract) Immune reconstitution and skewed responses after ART initiation in HIV I infected Ugandans | K. Nganou MakamdopView Slideset
SlidesetHIVINTEREST 2016(Abstract) Evaluating plasmatic biomarkers as disease signatures for the point of care monitoring of HIV-1 and comorbidities in resource limited regions | G. NchindaView Slideset
SlidesetHIVINTEREST 2016(Abstract) The effect of antiretroviral naïve HIV-1 infection on the ability of autologous NK cells to produce IFNg unpon exposure to Plasmodium falciparum- infected Erythrocytes | C. Sake NganeView Slideset
